44th Scientific Meeting
Update on Health, TMD and Sleep from a Global Perspective

May 7-10, 2020 • Orlando

PLENARY 21: Artificial Intellegence and Augmented Reality for Orofacial Pain – A (Human) Brainstorm on How They are Revolutionizing Pain Research, Education and Treatment

Alex DaSilva, DDS, DMedSc

Sunday, May 10, 2020 — 11:15 am – 12:00 pm

Meet our outstanding presenter. Dr. DaSilva is the Director of H.O.P.E. (Headache & Orofacial Pain Effort) Laboratory at the University of Michigan (UM), which is a multidisciplinary team that investigates the brain as a research and therapeutic target for chronic pain disorders, including migraine, TMD, head and neck cancer pain, and neuropathic pain. He is an Associate Professor in the Biologic and Materials Sciences Department at the UM School of Dentistry, Ann Arbor. He is also co-director of the Functional Near Infrared Spectroscopy (fNIRS) Lab at the UM Center for Human Growth and Development. Dr. DaSilva has received his Doctorate in Medical Science (DMedSc) degree in Oral Biology with clinical training in Orofacial Pain at Harvard University. His thesis demonstrated for the first time in vivo the somatotopic activation (fMRI) of trigeminal pain in the peripheral and central somatosensory pathway in humans. This work was followed by a post-doctoral fellowship on Migraine Neuroimaging at the Martinos Center for Biomedical Imaging, Massachusetts General Hospital, to investigate subcortical and cortical changes in the brains of migraine patients. He was also an Instructor in the Psychiatric Department at Harvard University/McLean Hospital, where he investigated the co-localization of functional and structural cortical neuroplasticity in Trigeminal Neuropathic Pain patients. With his colleagues at the UM H.O.P.E. lab, he has developed novel technologies for pain research, treatment, and education using molecular (e.g., μ-opioid and D2/D3 dopamine), functional and structural neuroimaging (PET, fNIRS and MRI-based), non-invasive brain stimulation, mobile technology, and augmented and virtual reality tools (AV/VR).

Dr. DaSilva’s research interests include health technology innovations for migraine/pain research, education and treatment, including the investigation and modulation of μ-opioid and dopamine mechanisms in pain, analgesia and addiction.

Meeting Recordings